Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer
2013 ◽
Vol 131
(1)
◽
pp. 169-173
◽
Keyword(s):
Phase I
◽